|Articles|February 1, 2007
eShowcase: Nextrials and Vitalograph
Partnership puts pulmonary data in the hands of researchers when and where they need it
Advertisement
Partnership puts pulmonary data in the hands of researchers when and where they need it
Nextrials, Inc. (San Ramon, CA) is partnering with Vitalograph (Lenexa, KS, and Buckingham, UK) to deliver expedited access to pulmonary function data collected during clinical trials. The system works by closely integrating Nextrials' Prism clinical trial management system with the Vitalograph Spirotrac Centralized Spirometry System.
As a result, biotechnology and medical device researchers can quickly evaluate pulmonary lung function, potentially improving patient safety. For researchers, real-time access to study data also translates into enhanced workflow and efficiency. Ultimately, this results in reduced costs and quicker time to market for new therapies. As a result of the collaboration, sponsors have access to a single product that provides all relevant data including pulmonary function information, in real time across multiple test sites and multiple studies.
Nextrials, Inc., (925) 355-3000, www.nextrials.com
Vitalograph, (800) 255-6626, www.vitalograph.com
Articles in this issue
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
2
Latest NIMBLE Study Results Highlight Progress in gMG Research
3
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
4
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
5